Biogen Idec (Nasdaq: BIIB) has presented detailed product and financial goals for the year 2010. Specifically, the company aims to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE